Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

Imbalance of plasma amino acids, metabolites and lipids in patients with lysinuric protein intolerance (LPI)

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Lipidome as a predictive tool in progression to type 2 diabetes in Finnish men

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Abnormal levels of adipokines in adolescent offspring of women with type 1 diabetes - Results from the EPICOM study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Vagotomy and subsequent development of diabetes - A nested case-control study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Lipidomic profiles, lipid trajectories and clinical biomarkers in female elite endurance athletes

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Circulating metabolites in progression to islet autoimmunity and type 1 diabetes

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Polyols and Branched Chained Amino Acids Are Associated with Present and Future Renal Impairment in Type 1 Diabetes

    Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

  4. Targeted Clinical Metabolite Profiling Platform for the Stratification of Diabetic Patients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Johanna Kurko
  • Maaria Tringham
  • Laura Tanner
  • Kirsti Näntö-Salonen
  • Mari Vähä-Mäkilä
  • Heli Nygren
  • Päivi Pöhö
  • Niina Lietzen
  • Ismo Mattila
  • Anu Olkku
  • Tuulia Hyötyläinen
  • Matej Orešič
  • Olli Simell
  • Harri Niinikoski
  • Juha Mykkänen
Vis graf over relationer

BACKGROUND: Lysinuric protein intolerance (LPI [MIM 222700]) is an aminoaciduria with defective transport of cationic amino acids in epithelial cells in the small intestine and proximal kidney tubules due to mutations in the SLC7A7 gene. LPI is characterized by protein malnutrition, failure to thrive and hyperammonemia. Many patients also suffer from combined hyperlipidemia and chronic kidney disease (CKD) with an unknown etiology.

METHODS: Here, we studied the plasma metabolomes of the Finnish LPI patients (n=26) and healthy control individuals (n=19) using a targeted platform for analysis of amino acids as well as two analytical platforms with comprehensive coverage of molecular lipids and polar metabolites.

RESULTS: Our results demonstrated that LPI patients have a dichotomy of amino acid profiles, with both decreased essential and increased non-essential amino acids. Altered levels of metabolites participating in pathways such as sugar, energy, amino acid and lipid metabolism were observed. Furthermore, of these metabolites, myo-inositol, threonic acid, 2,5-furandicarboxylic acid, galactaric acid, 4-hydroxyphenylacetic acid, indole-3-acetic acid and beta-aminoisobutyric acid associated significantly (P<0.001) with the CKD status. Lipid analysis showed reduced levels of phosphatidylcholines and elevated levels of triacylglycerols, of which long-chain triacylglycerols associated (P<0.01) with CKD.

CONCLUSIONS: This study revealed an amino acid imbalance affecting the basic cellular metabolism, disturbances in plasma lipid composition suggesting hepatic steatosis and fibrosis and novel metabolites correlating with CKD in LPI. In addition, the CKD-associated metabolite profile along with increased nitrite plasma levels suggests that LPI may be characterized by increased oxidative stress and apoptosis, altered microbial metabolism in the intestine and uremic toxicity.

TidsskriftMetabolism: Clinical and Experimental
Udgave nummer9
Sider (fra-til)1361-75
Antal sider15
StatusUdgivet - sep. 2016
Eksternt udgivetJa

ID: 54985472